Your browser doesn't support javascript.
loading
Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study.
Martin-Liberal, Juan; Garralda, Elena; García-Donas, Jesús; Soto-Castillo, Juan José; Mussetti, Alberto; Codony, Carles; Martin-Lluesma, Silvia; Muñoz, Susana; Galvao, Vladimir; Lostes, Julia; Rotxes, Marta; Prat-Vidal, Cristina; Palomero, Jara; Muñoz, Ainhoa; Moreno, Rafael; Del Muro, Xavier García; Sureda, Anna; Alemany, Ramon; Gros, Alena; Piulats, Josep Maria.
Affiliation
  • Martin-Liberal J; Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • García-Donas J; Centro Integral Oncológico Clara Campal (HM CIOCC), Madrid, Spain.
  • Soto-Castillo JJ; Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Mussetti A; Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Codony C; Institute of Biomedical Research of Bellvitge (IDIBELL), Barcelona, Spain.
  • Martin-Lluesma S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Muñoz S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Galvao V; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Lostes J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Rotxes M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Prat-Vidal C; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Palomero J; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Muñoz A; Institute of Biomedical Research of Bellvitge (IDIBELL), Barcelona, Spain.
  • Moreno R; Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Del Muro XG; Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Sureda A; Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Alemany R; Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Gros A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Piulats JM; Catalan Institute of Oncology (ICO), Barcelona, Spain.
Future Oncol ; : 1-9, 2024 Aug 12.
Article de En | MEDLINE | ID: mdl-39129675

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Future Oncol Année: 2024 Type de document: Article Pays d'affiliation: Espagne Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Future Oncol Année: 2024 Type de document: Article Pays d'affiliation: Espagne Pays de publication: Royaume-Uni